GLP-1 therapies Archives - Pharma Marketing Network

Home Tags GLP-1 therapies

GLP-1 injection pen creating ripple effects across multiple therapeutic areas including cardiovascular health, diabetes, sleep medicine, orthopedics, kidney disease, and liver health.

The GLP-1 Ripple Effect: How Obesity Drugs Are Rewriting Marketing Strategies...

Donna Pacheco - July 23, 2026

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

GLP-1 injection pen creating ripple effects across multiple therapeutic areas including cardiovascular health, diabetes, sleep medicine, orthopedics, kidney disease, and liver health.

The GLP-1 Ripple Effect: How Obesity Drugs Are Rewriting Marketing Strategies...

July 23, 2026

Healthcare professional comparing traditional Key Opinion Leaders with Digital Opinion Leaders using social media, podcasts, and online medical communities for pharmaceutical engagement.

DOLs vs. KOLs: Why Academic Credentials No Longer Guarantee Digital Influence

July 23, 2026

Pharmaceutical executives reviewing commercial performance metrics and market growth charts during a corporate strategy meeting, illustrating how marketing and corporate reputation influence investor confidence.

When Marketing Shapes Market Value: Why Investors Are Watching Commercial Execution...

July 22, 2026